N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5

Catalog No. :
ACLYXH401
CAS No. :
2107273-80-1
Molecular Formula :
C37H49ClN2O9S2
Molecular Weight :
765.39

IUPAC Name:2-((1E,3E,5Z)-5-(3-(2-(2-(2-(2-carboxyethoxy)ethoxy)ethoxy)ethyl)benzo[d]thiazol-2(3H)-ylidene)penta-1,3-dien-1-yl)-3-(2,5,8,11-tetraoxatridecan-13-yl)benzo[d]thiazol-3-ium chloride

N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$264.00Login to see priceInquiryInquiry
2mg98%$403.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5
IUPAC Name2-((1E,3E,5Z)-5-(3-(2-(2-(2-(2-carboxyethoxy)ethoxy)ethoxy)ethyl)benzo[d]thiazol-2(3H)-ylidene)penta-1,3-dien-1-yl)-3-(2,5,8,11-tetraoxatridecan-13-yl)benzo[d]thiazol-3-ium chloride
Molecular FormulaC37H49ClN2O9S2
Molecular Weight765.39
SMILESCOCCOCCOCCOCC[N+]1=C(SC2=CC=CC=C21)/C=C/C=C/C=C(SC3=C4C=CC=C3)/N4CCOCCOCCOCCC(O)=O.[Cl-]
InChI KeyPEWXFUQTWHPFTH-UHFFFAOYSA-N
SynonymN-(m-PEG4)-N'-(acid-PEG3)-Benzothiazole Cy5;N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5
CAS No.2107273-80-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLYXH401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYXH401 route product structure diagram
    ACLYXH4012107273-80-1
Inquiry

2. ACLYXH401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYXH401 route product structure diagram
    ACLYXH4012107273-80-1
Inquiry

Comments (0)